Active Biotech AB
Records under this name other than the patents Active Biotech AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,654,140 | Treatment of Ocular Inflammatory Diseases Using Laquinimod Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,293,243 | Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent Term ended Term ended May 12, 2026 · From the USPTO record | Term ended | Term ended May 12, 2026 | From the USPTO record |
| US 9,873,687 | N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitors Lapsed on the fee record Ended Jan 23, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 23, 2026 | From the USPTO record |
| US 8,598,203 | Treatment of Crohn's Disease with Laquinimod Lapsed on the fee record Ended Dec 3, 2025 · High confidence | Lapsed on the fee record | Ended Dec 3, 2025 | High confidence |
| US 9,771,372 | Compounds useful as S100-inhibitors Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |
| US 7,763,253 | Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent Term ended Term ended Aug 12, 2025 · From the USPTO record | Term ended | Term ended Aug 12, 2025 | From the USPTO record |
| US 8,754,104 | Crystalline salts of quinoline compounds and methods for preparing them Term ended Ended no later than Feb 4, 2025 · From the USPTO record | Term ended | Ended no later than Feb 4, 2025 | From the USPTO record |
| US 7,560,557 | Process for the manufacture of quinoline derivatives Term ended Term ended Jan 6, 2025 · From the USPTO record | Term ended | Term ended Jan 6, 2025 | From the USPTO record |
| US 8,314,124 | Crystalline salts of quinoline compounds and methods for preparing them Lapsed on the fee record Ended Nov 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2024 | From the USPTO record |
| US 7,255,867 | Vaccine Formerly held Term ended Term ended Dec 30, 2023 · From the USPTO record | Term ended | Term ended Dec 30, 2023 | From the USPTO record |